DOI 10.1016/j.ejca.2026.116881
Safety and efficacy of concurrent radiation therapy with amivantamab in patients with advanced EGFR- or MET-altered non-small cell lung cancer.
Аннотация
INTRODUCTION
Amivantamab is increasingly used in EGFR-altered advanced non-small cell lung cancer (NSCLC), but data on the safety and efficacy of concurrent radiation therapy (RT) remain scarce. This study assessed the safety and efficacy of this approach.
METHODS
Patients with advanced EGFR- or MET-altered NSCLC who received RT within 3 weeks after amivantamab were retrospectively analyzed. RT-related adverse events (AEs), best clinical and radiological responses, local control (LC), post-RT progression-free survival (PFS), overall survival (OS), time to treatment discontinuation (TTD), and time to new systemic therapy (TTNT) were assessed.
RESULTS
Twenty-one irradiation courses were delivered concurrently with amivantamab in 14 patients. Median age was 63 years; 71% were never-smokers; 86% had received prior systemic therapy. Mutations included EGFR ex19del (64%), L858R (14%), ex20ins (14%), and MET exon 14 skipping (7%). RT indications were oligoprogression (29%) and palliation (71%), targeting the brain (19%), thorax (19%), lumbosacral spine (14%), adrenals (10%), and extremities (10%). Median follow-up was 8.0 months for AEs and 9.5 months for oncologic outcomes. Symptom relief was achieved in 87% of irradiations, and LC was maintained in 80% of cases. RT-related AEs included 13 grade 1 acute, six grade 2 acute, and three grade 1 late events; no grade ≥ 3 AEs were reported. The 6- and 12-month OS rates were 77% and 50%, respectively. Among 11 patients continuing amivantamab after RT, median PFS, TTD, and TTNT were 4.5, 4.8, and 5.5 months, respectively. Symptom relief was achieved in 87% of palliative irradiations, and LC was maintained in 80% of oligoprogressive lesions.
CONCLUSIONS
Concurrent palliative RT and amivantamab appears feasible and well tolerated. Further validation is warranted.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.